Clinical practice. Prolactinomas
- PMID: 20357284
- DOI: 10.1056/NEJMcp0912025
Clinical practice. Prolactinomas
Erratum in
- N Engl J Med. 2010 Jun 3;362(22):2142
Similar articles
-
[Prolactinoma and pregnancy].Akush Ginekol (Sofiia). 2004;43 Suppl 2:16-22. Akush Ginekol (Sofiia). 2004. PMID: 15518268 Review. Bulgarian. No abstract available.
-
[Selection of management tactics in treatment of giant prolactin-secreting pituitary adenomas].Zh Vopr Neirokhir Im N N Burdenko. 2009 Apr-Jun;(2):23-8; discussion 28-9. Zh Vopr Neirokhir Im N N Burdenko. 2009. PMID: 19569545 Clinical Trial. Russian.
-
Medical management of prolactin-secreting pituitary adenomas.Pituitary. 2002;5(2):55-65. doi: 10.1023/a:1022375429083. Pituitary. 2002. PMID: 12675502 Review.
-
[Macroprolactinoma].Dtsch Med Wochenschr. 1996 Jul 26;121(30):962. Dtsch Med Wochenschr. 1996. PMID: 8777896 German. No abstract available.
-
The novel use of very high doses of cabergoline and a combination of testosterone and an aromatase inhibitor in the treatment of a giant prolactinoma.J Clin Endocrinol Metab. 2002 Oct;87(10):4447-51. doi: 10.1210/jc.2002-020426. J Clin Endocrinol Metab. 2002. PMID: 12364416
Cited by
-
Prolactinoma: Navigating the Dual Challenge of Side Effects and Treatment Strategies - A Comprehensive Review.Ann Med Surg (Lond). 2024 Jun 21;86(8):4613-4623. doi: 10.1097/MS9.0000000000002308. eCollection 2024 Aug. Ann Med Surg (Lond). 2024. PMID: 39118737 Free PMC article. Review.
-
A Non-Secreting Pituitary Adenoma That Changed to a Prolactinoma.Clin Pract. 2024 Jul 4;14(4):1310-1318. doi: 10.3390/clinpract14040106. Clin Pract. 2024. PMID: 39051300 Free PMC article.
-
Metabolic and inflammatory parameters in relation to baseline characterization and treatment outcome in patients with prolactinoma: insights from a retrospective cohort study at a single tertiary center.Front Endocrinol (Lausanne). 2024 Apr 5;15:1363939. doi: 10.3389/fendo.2024.1363939. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38645431 Free PMC article.
-
Suppressive Effects of Neuromedin U Receptor 2-Selective Peptide Agonists on Appetite and Prolactin Secretion in Mice.ACS Med Chem Lett. 2024 Feb 14;15(3):376-380. doi: 10.1021/acsmedchemlett.3c00541. eCollection 2024 Mar 14. ACS Med Chem Lett. 2024. PMID: 38505846
-
Reconsideration of Surgical Indication for Prolactin-producing Pituitary Tumor Focusing on Visual Impairment.Neurol Med Chir (Tokyo). 2024 Apr 15;64(4):160-167. doi: 10.2176/jns-nmc.2023-0184. Epub 2024 Feb 15. Neurol Med Chir (Tokyo). 2024. PMID: 38355129 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical